Skip to main content

Clinical Trials Search at Vanderbilt-Ingram Cancer Center



A Phase I Study with an Expansion Cohort of the Combinations of Ipilimumab, Nivolumab and Brentuximab Vedotin in Patients with Relapsed/Refractory Hodgkin Lymphoma

Multiple Cancer Types

Lymphoma, Phase I
I
Friedman, Debra
NCT01896999
COGE4412

To learn more about any of our clinical
trials, call 615-936-8422.